Pemdrax 500 Injection contains Pemetrexed 500mg, a potent antineoplastic chemotherapy agent indicated for the treatment of non-small cell lung cancer and malignant pleural mesothelioma. It plays a vital role in controlling tumor progression and improving treatment outcomes in advanced oncology care.
Pemetrexed acts by inhibiting multiple folate-dependent enzymes required for DNA and RNA synthesis in cancer cells, thereby suppressing cell division and inducing apoptosis. Its injectable formulation ensures precise dosing under supervised oncology protocols.
For distributors and healthcare suppliers, Pemdrax 500 Injection is a critical oncology therapy product, widely utilized in tertiary care hospitals, cancer specialty centers, and oncology clinics. The increasing global burden of lung cancer supports sustained demand in the oncology segment.
Adding Pemdrax 500 Injection to your oncology and anticancer therapy segment creates strong opportunities in hospital supply networks, specialty cancer institutions, export markets, and third-party manufacturing. Its proven clinical relevance, prescriber confidence, and essential role in chemotherapy regimens make it a valuable pharmaceutical offering.
Common side effects may include nausea, vomiting, fatigue, loss of appetite, mucositis, and bone marrow suppression leading to anemia, leukopenia, or thrombocytopenia. Rare but serious side effects include severe infections, renal toxicity, or hypersensitivity reactions. Immediate medical attention is required if severe adverse effects occur.
Pemdrax 500 Injection is indicated for the treatment of malignant pleural mesothelioma and non-small cell lung cancer (NSCLC), either as monotherapy or in combination with other anticancer agents, as prescribed by an oncologist.
Pemdrax 500 Injection must be administered only by qualified healthcare professionals in a hospital or oncology setting. Folic acid and vitamin B12 supplementation are recommended to reduce treatment-related toxicity. Regular monitoring of blood counts and kidney function is essential throughout therapy.
Store Pemdrax 500 Injection in a cool, dry place between 2–8°C, protected from light. Keep out of reach of children. Use reconstituted solution immediately or as directed by the manufacturer. Do not use the injection beyond the expiry date printed on the vial.